IL-22 is a molecule that is important in intestinal epithelial homeostasis, but that may also contribute to tumor cell division and survival. IL-22 is produced by immune cells, including subsets of innate lymphoid cells that mainly reside in mucosal tissues.
The overall goal of Dr. Bando’s research is to decipher how IL-22 secretion by innate lymphoid cells is regulated in different organs in order to develop strategies to control the production of this cytokine.
Projects and Grants
Immune modulation of dormant skin tumor development and persistence
Washington University School of Medicine | All Cancers | 2016 | Marco Colonna, M.D.
Let's spread the word about Immunotherapy! Click to share this page with your community.